Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris
aHilary Baldwin, MD; bDaisy Blanco, MD; cCharles McKeever, MD; dNelly Paz, MD; eYnca Nina Vasquez, MD; fJohn Quiring, PhD; gCarolyn Enloe, MPH; gEmily de León, MSCR; gNathan Stasko, PhD aAcne